|
|
BrightGene Bio-Medical Technology Co Ltd A
SHSE •
Healthcare •
Biotechnology •
Quote as of 06/12/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeSHSE
Market Capitalization22,570 mln
Float278 mln
P / E
367
Bubble territory
Key Fundamentals
EPS0.12
P/E367
ROE2.04
RPS3.05
ROIC2.77
ROA0.90
Interest Cover2.00
EBITDA, mln88.86
EV / EBITDA292
EV / EBIT292
Revenue, mln1,300
EV / Revenue19.94
Financial Strength
Altman Z-Score4.5
Piotroski F-Score
5
/ 9
Beneish M-Score-2.12
Price to Graham Number11.91
Shiller PE Ratio150
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-6.91% |
16
/ 100
 |
| 1 Month |
-30.17% |
1
/ 100
 |
| 2 Months |
7.13% |
78
/ 100
 |
| 6 Months |
-15.88% |
30
/ 100
 |
| 1 Year |
-15.44% |
18
/ 100
|
|
| |
